Imitrex (Sumatriptan) Dosing for Migraine Treatment
For oral sumatriptan, start with 50-100 mg at migraine onset, which can be repeated after 2 hours if needed, with a maximum of 200 mg per 24 hours. 1
Route-Specific Dosing Regimens
Oral Administration
- Initial dose: 25 mg, 50 mg, or 100 mg at onset of migraine 1
- The 50 mg and 100 mg doses provide greater efficacy than 25 mg, though 100 mg may not offer significant advantage over 50 mg 1
- If headache persists or returns after 2 hours, repeat the dose with at least 2 hours between doses 1
- Maximum daily dose: 200 mg in 24 hours 2, 1
- The 50 mg dose offers the best balance of efficacy and tolerability, though many patients prefer or require 100 mg 3
Subcutaneous Administration
- Initial dose: 6 mg at migraine onset 2, 4, 5
- Can repeat once after 1 hour if needed 2, 4
- Maximum: 12 mg per 24 hours 2, 4, 5
- Provides fastest relief (within 15 minutes) with highest efficacy (70-82% response rate) 4
Intranasal Administration
- Initial dose: 5-20 mg (one to two sprays) in one nostril 2, 4, 5
- Can repeat after 2 hours if needed 2, 4, 5
- Maximum: 40 mg per 24 hours 2, 4, 5
Critical Timing Considerations
- Administer early in the headache phase when pain is still mild for optimal effectiveness 4
- Do not use during migraine aura 6
- Patients should trial sumatriptan for 2-3 headache episodes before determining effectiveness 4, 5, 7
Managing Inadequate Response
- If monotherapy fails, combine sumatriptan with an NSAID or acetaminophen 7
- Approximately 40% of patients experience headache recurrence within 8-12 hours, which can be treated with a second dose following minimum interval requirements 4, 6
- If inadequate response after dose optimization, switch to another triptan (almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, or zolmitriptan) 7
Absolute Contraindications
- Coronary artery disease, previous myocardial infarction, or Prinzmetal angina 4, 6
- Hemiplegic or basilar migraine 2, 4, 5
- Uncontrolled hypertension 4, 6
- Use within 24 hours of ergotamine or another triptan 2, 4, 5
- Current MAOI use 2, 4, 5
- Pregnancy 2, 5
- Impaired hepatic function (if used, maximum single dose 50 mg) 2, 5, 1
Common Adverse Effects
- Oral: nausea, warmth, vomiting, vertigo, malaise, fatigue, dizziness 2, 7, 6
- Subcutaneous: injection site reactions (approximately 30% of patients), chest pressure and heaviness 5, 7, 6
- Chest symptoms occur in 3-5% of patients but rarely associated with myocardial ischemia 4, 6
Critical Safety Warning
Frequent, repeated use of sumatriptan risks development of medication overuse headache 4. The safety of treating more than 4 headaches in a 30-day period has not been established 1.